Axsome Therapeutics Shares Rally 63%; Reports Q4 on Feb. 23 with +30% ESP
Axsome Therapeutics shares have risen 63.1% over the past six months after beating earnings estimates in three of the last four quarters with an average surprise of 8.47%. The company’s Earnings ESP stands at +30% with a Zacks Rank #3 ahead of its February 23 Q4 report.
1. Share Performance
Axsome Therapeutics shares have climbed 63.1% over the past six months, outperforming peers on strong market momentum and growing investor interest.
2. Earnings Surprise History
The company has beaten earnings estimates in three of the past four quarters, delivering an average surprise of 8.47%, reflecting solid operational execution and cost management.
3. Upcoming Q4 Expectations
Axsome is set to report fourth-quarter results on February 23, carrying a +30% Earnings ESP and a Zacks Rank #3, which suggests a cautiously optimistic outlook from analysts.